nnmt inhibitor 5-amino-1mq clinical trial 5A-1-Molecule (5 Amino 1mq) 50mg

Suppresses lipogenesis by reducing acetyl-CoA carboxylase activity in cells

If your fatigue, brain fog, or tingling returns before your next scheduled shot, it is important to communicate this to your care team

Administered intramuscularly, these shots bypass the digestive system, allowing for immediate absorption into the bloodstream

Therapeutic-Model Protocol Dose: 0.50 1.00 mg (= 2040 clicks) Duration: 6 8 weeks Frequency: Daily Cycle Interval: 2 3 weeks off between cycles Goal / Description: Higher dose to assess enhanced lipolysis and energy utilization

AOD-9604 Supplies Needed Plan based on subcutaneous research dosing of 300-500 mcg/day from a 5 mg vial reconstituted with 3.0 mL bacteriostatic water